Search Results - "Limmroth, V."

Prevalence of migraine, tension-type headache and trigeminal neuralgia in multiple sclerosis by Putzki, N., Pfriem, A., Limmroth, V., Yaldizli, Ö., Tettenborn, B., Diener, H. C., Katsarava, Z.

“…Background:  Prevalence rates of headache in multiple sclerosis (MS) patients varied widely in recent studies. This study aimed to investigate the 1 year…”
Get full text

Guidelines for controlled trials of prophylactic treatment of chronic migraine in adults by Silberstein, S, Tfelt-Hansen, P, Dodick, D W, Limmroth, V, Lipton, R B, Pascual, J, Wang, S J

“…In 1991 the Clinical Trials Subcommittee of the International Headache Society (IHS) developed and published its first edition of the Guidelines on controlled…”
Get more information

Features of medication overuse headache following overuse of different acute headache drugs by LIMMROTH, V, KATSARAVA, Z, FRITSCHE, G, PRZYWARA, S, DIENER, H.-C

“…To investigate pharmacologic features such as mean critical duration until onset of medication-overuse headache (MOH) (MCDO), mean critical monthly intake…”
Get full text

Lamotrigine reduces migraine aura and migraine attacks in patients with migraine with aura by Lampl, C, Katsarava, Z, Diener, H-C, Limmroth, V

“…This study examined the efficacy of lamotrigine in the prevention of migraine aura. Fifty nine patients suffering from migraine with aura received lamotrigine…”
Get full text

Clinical features of withdrawal headache following overuse of triptans and other headache drugs by KATSARAVA, Z, FRITSCHE, G, MUESSIG, M, DIENER, H. C, LIMMROTH, V

“…Complete withdrawal from headache medication is the treatment of choice for medication-overuse headache. Discontinuation of the overused headache medication,…”
Get full text

Incidence and predictors for chronicity of headache in patients with episodic migraine by KATSARAVA, Z, SCHNEEWEISS, S, KURTH, T, KROENER, U, FRITSCHE, G, EIKERMANN, A, DIENER, H.-C, LIMMROTH, V

“…The authors followed 532 consecutive patients with episodic migraine (<15 days/month) for 1 year. Sixty-four patients (14%) developed chronic headache (>/=15…”
Get full text

Medication overuse headache: rates and predictors for relapse in a 4-year prospective study by Katsarava, Z, Muessig, M, Dzagnidze, A, Fritsche, G, Diener, H C, Limmroth, V

“…We present a prospective 4-year follow-up study of 96 patients with medication overuse headache following withdrawal. Complete datasets were available from 85…”
Get more information

Central sensitization of the trigeminal and somatic nociceptive systems in medication overuse headache mainly involves cerebral supraspinal structures by Ayzenberg, I, Obermann, M, Nyhuis, P, Gastpar, M, Limmroth, V, Diener, H C, Kaube, H, Katsarava, Z

“…Trigeminal and somatic nociceptive systems were studied in controls (n=15), episodic migraine (n=16), analgesics (n=14) and triptan-induced medication overuse…”
Get more information

P050 Does rTMS and/or tDCS improve the outcome of behavioral aphasia therapy in subacute aphasia? by Rubi-Fessen, I, Thiel, A, Hartmann, A, Riecker, A, Zumbandsen, A, Limmroth, V, Heiss, W.- D

“…Introduction For several years non invasive brain stimulation (NIBS) techniques like rTMS and tDCS were used in combination with speech and language therapy…”
Get full text

Könnte Salz Autoimmunerkrankungen triggern? by Limmroth, V.

“…Salz scheint autoimmunologische Prozesse zu aktivieren und zu intensivieren. Krankheiten wie die multiple Sklerose (MS) könnten so befördert werden. Die erste…”
Get full text

Prednisone vs. placebo in withdrawal therapy following medication overuse headache by Pageler, L, Katsarava, Z, Diener, H C, Limmroth, V

“…This proof-of-concept study evaluated the efficacy of prednisone for the treatment of withdrawal symptoms in patients with medication overuse headache (MOH) in…”
Get more information

Relapsing neuromyelitis optica responsive to glatiramer acetate treatment by Gartzen, K, Limmroth, V, Putzki, N

Get full text

Prevalence of trigeminal autonomic symptoms in migraine: a population-based study by Obermann, M, Yoon, M-S, Dommes, P, Kuznetsova, J, Maschke, M, Weimar, C, Limmroth, V, Diener, H C, Katsarava, Z

“…Epidemiological data on trigeminal unilateral autonomic symptoms in patients with migraine are scarce. The authors wanted to provide a population-based…”
Get more information

Efficacy of natalizumab in second line therapy of relapsing-remitting multiple sclerosis: results from a multi-center study in German speaking countries by Putzki, N., Yaldizli, O., Mäurer, M., Cursiefen, S., Kuckert, S., Klawe, C., Maschke, M., Tettenborn, B., Limmroth, V.

“…Background:  Natalizumab has been recommended for the treatment of relapsing–remitting multiple sclerosis (RRMS) in patients with insufficient response to…”
Get full text

Autoinjector preference among patients with multiple sclerosis: results from a national survey by Limmroth, V, Reischl, J, Mann, B, Morosov, X, Kokoschka, A, Weller, I, Schreiner, T

“…Autoinjectors are well-established in supporting multiple sclerosis (MS) therapy. This market survey was aimed at investigating patients' rating of three…”
Get full text

Weekly IM interferon beta-1a in multiple sclerosis patients over 50 years of age by Lampl, C., You, X., Limmroth, V.

“…Background:  Efficacy and safety data have not previously been compiled for intramuscular interferon beta‐1a (IM IFNβ‐1a) in patients with multiple sclerosis…”
Get full text

Natalizumab is effective as second line therapy in the treatment of relapsing remitting multiple sclerosis by Putzki, N., Kollia, K., Woods, S., Igwe, E., Diener, H. C., Limmroth, V.

“…Background:  Natalizumab has been recommended for the treatment of patients with relapsing remitting multiple sclerosis with insufficient response to…”
Get full text

Brain stem activation in spontaneous human migraine attacks by Weiller, C, May, A, Limmroth, V, Jüptner, M, Kaube, H, Schayck, R.V, Coenen, H.H, Dlener, H.C

“…Evidence from animal experiments shows that the brain stem is involved in the pathophysiology of migraine. To investigate human migraine, we used positron…”
Get full text

Rates and predictors for relapse in medication overuse headache: A 1-year prospective study by KATSARAVA, Z, LIMMROTH, V, FINKE, M, DIENER, H. C, FRITSCHE, G

“…The authors prospectively studied 98 patients with medication overuse headache. The 1-year relapse rate was 38% but was lower for patients with migraine…”
Get full text

Juvenile MS zunehmend häufiger by Limmroth, V.

“…In den letzten Jahren mehrten sich übereinstimmend die Hinweise, dass sowohl Prävalenz als auch Inzidenz der Multiplen Sklerose (MS) in allen Ländern, in denen…”
Get full text